Ajanta Pharma Limited (AJANTPHARM.BO)
BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹3,348.60 (-1.71%) as of
Key statistics
- Market cap
- 418.36B
- P/E (TTM)
- 41.28
- Forward P/E
- 33.69
- EPS (TTM)
- 81.11
- Dividend yield
- 1.98%
- 52-week range
- 2,022.05 – 3,527.35
- Beta
- 0.16
- Revenue (TTM)
- 52.02B
- Profit margin
- 19.50%
- Analyst target
- ₹3,207.58
- Volume
- 5.77k
About Ajanta Pharma Limited
Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic areas comprising cardiology, dermatology, ophthalmology, and pain management. The company operates in India, Africa, Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Mumbai, India
- Employees
- 9,628
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.
Related stocks
- RATTANINDIA ENTERPRISES LIMITE (RTNINDIA.BO)
- Rikhav Securities Limited (RIKHAV.BO)
- Restaurant Brands Asia Limited (RBA.BO)
- SPACENET ENTERS IND LTD (SPCENET.NS)
- DIGIKORE STUDIOS LIMITED (DIGIKORE-SM.NS)
- GLOBE CIVIL PROJECTS LTD (GLOBECIVIL.NS)
- BHAGYANAGAR INDIA LIMITED (BHAGYANGR.NS)
- SANOFI INDIA LTD (SANOFI.BO)